28 January 2021
1300 794 893
Subscribe

The link between diabetes and cancer

24 October 2020

More videos

Stocks fund managers like: Nuix, Sezzle, Redbubble, Lynas and Telstra!!

In this week's show, Peter Switzer speaks to Jun Bei Liu, Julia Lee, Paul Rickard and Michael Terpin.

Mad about Money Live

Join Peter Switzer and Paul Rickard for the latest money news in a new live episode of Mad about Money!

Peter Cook from Novatti Group (ASX:NOV)

Peter Switzer sits down with the CEO of Novatti (NOV), Peter Cook.

Another new treatment for Glioblastoma

Dr Ross Walker talks about another new trial into treating Glioblastoma, one of the most aggressive brain cancers.

Will dividends rebound better than expected in 2021?

Peter Switzer and Paul Rickard take a look back on what happened to dividends in 2020 and what is likely to happen in 2021.

Will HospoKeeper replace JobKeeper?

Peter Switzer and Paul Rickard look at the potential replacements to JobKeeper, why Wall Street likes Joe Biden and what JB Hi-Fi's strong sales numbers mean for the economy.

Dr Chris Hart from Oventus Medical (ASX:OVN)

Peter Switzer speaks to the founder and CEO of Oventus (OVN), Dr Chris Hart.

BUY or SELL these hot stocks: Tyro, Z1P, A2M, ELO, EML, TWE, NXT and MP1

On this week's show, Peter Switzer is joined by Fairmont Equities' Michael Gable, Burman Invest's Julia Lee, Switzer's Paul Rickard and Avecho's Dr Paul Gavin.

Brian Ward from Aroa Biosurgery (ASX:ARX)

Peter Switzer is joined by Brian Ward, the founder and CEO of soft tissue regeneration company Aroa (ARX).

Two new treatments for Glioblastoma

Dr Ross Walker explains two studies that are finding new treatments for Glioblastoma, one of the most devastating kinds of brain tumour.

Rob Bromage from IntelliHR (ASX:IHR)

IntelliHR CEO Rob Bromage speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020.

Peter Switzer & Paul Rickard look at the stocks they like for 2021

Peter and Paul take a look back on 2020 and look ahead to the stocks that will do well in 2021, plus highlights from an interview with technology entrepreneur Bevan Slattery.

1 2 3 43
Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
1300 794 893
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homephoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram